Hims & Hers CEO granted 413,844 RSUs

Dudum Andrew reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Dudum Andrew reported acquisition or exercise transactions in this Form 4 filing.

Hims & Hers Health, Inc. Chief Executive Officer Andrew Dudum received a grant of 413,844 Restricted Stock Units. Each RSU represents a contingent right to receive one share of Class A common stock, so the award ties his compensation directly to future share value.

The RSUs vest over four years in substantially equal quarterly installments on March 15, June 15, September 15, and December 15, starting on June 15, 2026. Shares are delivered only as units vest, encouraging long-term service and alignment with shareholders rather than reflecting an open-market purchase.

Insider Trade Summary

Grant/Award: 413,844 shares

Grant/Award 1 txn

Insider Dudum Andrew

Role Chief Executive Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Unit	413,844	$0.00	$0.00

Holdings After Transaction: Restricted Stock Unit — 413,844 contracts (Direct)

Footnotes (2)

1. F1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
2. F2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Hims & Hers (HIMS) report for CEO Andrew Dudum?

Hims & Hers reported a grant of 413,844 Restricted Stock Units to CEO Andrew Dudum. Each RSU can convert into one share of Class A common stock, providing stock-based compensation linked to the company’s future performance and his continued service over several years.

How many RSUs did the Hims & Hers (HIMS) CEO receive in this Form 4?

The CEO received 413,844 Restricted Stock Units in this reported transaction. These RSUs give him a contingent right to receive an equal number of Class A common shares, subject to the vesting schedule set out over a four-year service period with quarterly vesting dates.

What is the vesting schedule for the 413,844 RSUs granted by Hims & Hers (HIMS)?

The 413,844 RSUs vest over four years in substantially equal quarterly installments. Vesting occurs on March 15, June 15, September 15, and December 15, with the first vesting date on June 15, 2026, aligning the CEO’s rewards with multi-year company performance.

Does the Hims & Hers (HIMS) RSU grant to the CEO involve an open-market stock purchase?

The RSU grant does not involve an open-market stock purchase. Instead, it is a stock-based compensation award where each unit represents a contingent right to receive one share of Class A common stock as service-based vesting conditions are satisfied over time.

What does each RSU granted by Hims & Hers (HIMS) to the CEO represent?

Each RSU represents a contingent right to receive one share of Hims & Hers Class A common stock. The CEO only receives actual shares when the RSUs vest under the four-year, quarterly vesting schedule, linking his compensation to long-term company performance and retention.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 04:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dudum Andrew

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/11/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/11/2026		A		413,844		(2)	(2)	Class A Common Stock	413,844	$0	413,844	D

Explanation of Responses:

1. The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.

2. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on June 15, 2026.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum	03/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.